Efficacy of long-acting growth hormone in Axenfeld-Rieger syndrome with a novel 3.824 Mb 4q25 deletion: a Case Report and systematic literature review

Shihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin · 2026

Read Efficacy of long-acting growth hormone in Axenfeld-Rieger syndrome with a novel 3.824 Mb 4q25 deletion: a Case Report and systematic literature review by Shihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318242.txt.

Description

Shihui Guan and colleagues report a 2026 case of Axenfeld-Rieger syndrome, a multi-system disorder of eye and tooth development, in a young boy whose missing chromosome stretch also shut down growth hormone. Pairing the case with a literature review, they test whether deletion size predicts hormone failure.

Family gene sequencing in the 5.4-year-old found a fresh 3.824 megabase deletion at chromosome band 4q25, removing PITX2 and neighbors. His growth hormone peak was just 4.22 in stimulation testing, with bone age lagging by a year and a half. Twenty months on long-acting hormone therapy gained him 16.5 centimeters and restored a normal height range. Ten reviewed cases supported the size link. Growth checks, they urge, belong in routine care for deletion carriers.

Catalog record

CREATORShihui Guan, Jinyu Wang, Zhenxian Liu, Yangfan Qi, Xiaoyu Sun, Kai Jiang, Shuangzhu Lin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29596
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13318242

Browse the full library · About the Tower of Babel